A novel platelet-agglutinating protein (PAP) was purified approximately 2,000-fold from the plasma of a patient with thrombotic thrombocytopenic purpura (TTP) by ammonium sulfate fractionation, DEAE-Sephacel and concanavalin A-Sepharose chromatographies. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with and without reduction, this preparation revealed a major protein band with a molecular weight of 37,000, and a minor band with a molecular weight of 32,000-34,000. After elution from the gel, only the 37,000-mol wt protein corresponding to the major band induced the platelet agglutination. When four normal plasmas and the recovery plasma from the same TTP patient were subjected to the similar purification steps, the 37,000-mol wt major band was absent. The 125I-PAP bound to the platelets in a concentration-dependent manner. The platelet agglutination induced by PAP was not inhibited by hirudin, heparin in the presence of antithrombin III, phenylmethylsulfonyl fluoride, apyrase, aspirin, or prostaglandin I2. However, it was inhibited by IgG from normal adults and from the same TTP patient after recovery. The anti-37,000-mol wt PAP antiserum prepared in the rabbit formed a single precipitin line against the highly purified PAP. Using this antiserum in the Western immunoblotting, the 37,000-mol wt protein band was found in the three TTP plasmas, of which the platelet-agglutinating activity was inhibited by the anti-37,000-mol wt PAP IgG. The 37,000-mol wt immunoprecipitin band was absent in the plasmas obtained from another two TTP patients, two normal subjects, two patients with idiopathic thrombocytopenic purpura, and two patients with disseminated intravascular coagulation. These results suggest that the 37,000-mol wt PAP is present only in certain cases of TTP, and is likely to be responsible for the formation of platelet thrombi in the microcirculation.
F A Siddiqui, E C Lian
Title and authors | Publication | Year |
---|---|---|
ADAMTS13
GM Rodgers |
2015 | |
Thrombotic microangiopathy in haematopoietic cell transplantation: an update
E Stavrou, HM Lazarus |
Mediterranean journal of hematology and infectious diseases | 2010 |
Thrombotic Thrombocytopenic Purpura
JL Moake |
Consultative Hemostasis and Thrombosis | 2007 |
Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura
S Shariatmadar, M Nassiri, V Vincek |
American Journal of Hematology | 2005 |
Thrombotic thrombocytopenic purpura
B Lammle, JA Hovinga, L Alberio |
Journal of Thrombosis and Haemostasis | 2005 |
Thrombotic Thrombocytopenic Purpura: Yesterday, Today, Tomorrow
LJ McCarthy, JS Dlott, A Orazi, D Waxman, CC Miraglia, CF Danielson |
Therapeutic Apheresis and Dialysis | 2004 |
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura
M Furlan |
Expert Review of Cardiovascular Therapy | 2003 |
Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura
C Nabhan, HC Kwaan |
Hematology/Oncology Clinics of North America | 2003 |
Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity
FA Siddiqui, JL Francis |
Blood Coagulation & Fibrinolysis | 2002 |
Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion
EM Cosmai, L Puzis, HM Tsai, EC Lian |
European Journal of Haematology | 2002 |
Platelet-Agglutinating Protein p37 from a Patient with Thrombotic Thrombocytopenic Purpura Has Characteristics Similar to Prethrombin 2
SH Kim, SJ Park, JW Lee, JY Jin |
Journal of Biochemistry and molecular biology | 2002 |
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease
M Furlan, B Lämmle |
Best Practice & Research Clinical Haematology | 2001 |
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy, WC Nichols, EC Lian, T Foroud, JN McClintick, BM McGee, AY Yang, DR Siemieniak, KR Stark, R Gruppo, R Sarode, SB Shurin, V Chandrasekaran, SP Stabler, H Sabio, EE Bouhassira, JD Upshaw, D Ginsburg, HM Tsai |
Nature | 2001 |
Purification and Properties of Human Melanoma Cell Tissue Factor
FA Siddiqui, A Amirkhosravi, M Amaya, H Desai, T Meyer, JL Francis |
Clinical and Applied Thrombosis/Hemostasis | 2001 |
Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura
J Volcy, CM Nzerue, A Oderinde, K Hewan-Iowe |
American Journal of Kidney Diseases | 2000 |
Plasma from a Patient with Thrombotic Thrombocytopenic Purpura Induces Endothelial Cell Apoptosis and Platelet Aggregation
XW Wu, QZ Li, EC Lian |
Thrombosis Research | 1999 |
Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura
JJ Hong, HC Kwaan |
Hematology | 1999 |
Yearbook of Intensive Care and Emergency Medicine 1999
JL Vincent |
1999 | |
Thrombotic Thrombocytopenic Purpura: Understanding a Disease No Longer Rare
JL Moake, TW Chow |
The American Journal of the Medical Sciences | 1998 |
ANTIBODIES TO VON WILLEBRAND FACTOR–CLEAVING PROTEASE IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA
HM Tsai, EC Lian |
The New England journal of medicine | 1998 |
Increased Plasma Soluble-adhesion Molecules in Thrombotic Thrombocytopenic Purpura and Disseminated Intravascular Coagulation
M Shimura, H Wada, K Hiyoyama, T Nakasaki, M Takagi, A Deguchi, Y Mori, M Nisikawa, K Deguchi, H Shiku |
Clinical and Applied Thrombosis/Hemostasis | 1998 |
Indications for Emergency Apheresis Procedures
LJ McCarthy, CF Danielson, SS Rothenberger, AA Pineda |
Critical Reviews in Clinical Laboratory Sciences | 1997 |
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry |
1997 | |
Applications of Therapeutic Apheresis in Patients with Malignant Disease
AA Pineda, EC Vamvakas |
The oncologist | 1997 |
The pathophysiology and management of thrombotic thrombocytopenic purpura
P Ruggenenti, G Remuzzi |
European Journal of Haematology | 1996 |
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura
D Karpman, L Holmberg, L Jirgård, S Lethagen |
Kidney International | 1996 |
Acute Renal Failure
R Thadhani, M Pascual, JV Bonventre |
New England Journal of Medicine | 1996 |
Haemolytic-uraemic syndrome: basic science
JL Moake |
The Lancet | 1994 |
Anti-CD36 antibodies in thrombotic thrombocytopenic purpura
NN Tandon, G Rock, GA Jamieson |
British Journal of Haematology | 1994 |
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick |
Annals of the New York Academy of Sciences | 1994 |
Increased serum levels of transforming growth factor β-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis
G Zauli, L Gugliotta, L Catani, N Vianelli, P Borgatti, MM Belmonte, S Tura |
British Journal of Haematology | 1993 |
Mechanism of platelet aggregation induced by a monoclonal antibody requiring Fc portion
AX Yu, XW Wu, JZ Li, EC Lian |
Thrombosis Research | 1993 |
Haemolytic—Uraemic Syndrome and Thrombotic Thrombocytopenic Purpura
P Ruggenenti, G Remuzzi |
1993 | |
Plasma cytokine levels in thrombotic thrombocytopenic purpura
H Wada, T Kaneko, M Ohiwa, M Tanigawa, S Tamaki, N Minami, H Takahashi, K Deguchi, T Nakano, S Shirakawa |
American Journal of Hematology | 1992 |
Thrombotic thrombocytopenic purpura: Clinical results of a French controlled trial
P Henon |
Transfusion Science | 1992 |
von Willebrand factor (vWF) abnormalities in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS)
JL Moake |
Transfusion Science | 1992 |
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission
MM Chintagumpala, RL Hurwitz, JL Moake, DH Mahoney, CP Steuber |
The Journal of Pediatrics | 1992 |
Collateral therapy of thrombotic thrombocytopenic purpura with emphasis on high doses of gamma globulin
A Canevari, D Inverardi |
Transfusion Science | 1992 |
Treatment of HUS/TTP
DC Brennan, DL Sommerfeld, JA Gordon |
American Journal of Kidney Diseases | 1992 |
Diagnostische Hämatologie
H Huber, H Löffler, D Pastner |
1992 | |
Thrombotic microangiopathies
P Ruggenenti, G Remuzzi |
Critical Reviews in Oncology/Hematology | 1991 |
Circulating thrombomodulin in thrombotic thrombocytopenic purpura
H Takahashi, M Hanano, K Wada, W Tatewaki, H Niwano, A Shibata, J Tsubouchi, M Nakano, T Nakamura |
American Journal of Hematology | 1991 |
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura
A Falanga, R Consonni, P Ruggenenti, T Barbui |
British Journal of Haematology | 1991 |
Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome
JL Moake, PD McPherson |
Transfusion Medicine Reviews | 1990 |
Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome
J Monteagudo, A Pereira, S Roig, JC Reverter, A Ordinas, R Castillo |
American Journal of Hematology | 1990 |
Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: Clinical significance of anti-platelet antibodies
Y Itoh, H Sekine, O Hosono, T Takeuchi, J Koide, M Takano, T Abe |
Clinical Immunology and Immunopathology | 1990 |
Thrombotic Thrombocytopenic Purpura and Related Disorders
P Ruggenenti, G Remuzzi |
Hematology/Oncology Clinics of North America | 1990 |
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien |
1990 | |
Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein S
H Takahashi, W Tatewaki, T Nakamura, M Hanano, K Wada, A Shibata |
American Journal of Hematology | 1989 |
Thrombin generation in patients with thrombotic thrombocytopenic purpura
H Takahashi, W Tatewaki, K Wada, A Shibata |
American Journal of Hematology | 1989 |
Electron microscopic study of platelet agglutination induced by thrombotic thrombocytopenic purpura plasma containing 37-KDa platelet agglutinating protein
JZ Li, JW Liu, G Benito, FA Siddiqui, EC Lian |
Thrombosis Research | 1989 |
Thrombotic Thrombocytopenic Purpura: Successful Treatment Unlocks Etiologic Secrets
JL Schmidt |
Mayo Clinic Proceedings | 1989 |
Abnormal platelet von willebrand factor interaction in patients with TTP
G Rock, P Tittley, JR Taylor |
American Journal of Hematology | 1988 |
Permanent neurological complications in patients with thrombotic thrombocytopenic purpura
D Ben-Yehuda, M Rose, Y Michaeli, A Eldor |
American Journal of Hematology | 1988 |
Contemporary Internal Medicine
J Bowen, EL Mazzaferri |
1988 | |
Platelet-Vessel Wall Interactions
RM Pittilo, SJ Machin |
1988 | |
HUS and TTP: Variable expression of a single entity
G Remuzzi, S Garella |
Kidney International | 1987 |
Acute Thrombocytopenia and Thrombosis
JG Kelton, WG Murphy |
Annals of the New York Academy of Sciences | 1987 |
High incidence of relapses in thrombotic thrombocytopenic purpura
M Rose, A Eldor |
The American Journal of Medicine | 1987 |
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome
N Schlegel, J Maclouf, C Loirat, L Drouet, R Marotte, PY Scarabin, H Mathieu |
The Journal of Pediatrics | 1987 |
Plasmapheresis: Development and Application in Treatment of Renal Disorders
JE Balow |
Artificial Organs | 1986 |